TLDR
- Rocket Lab signed a multi-launch deal with iQPS for three more Electron missions, starting in 2028.
- The new contract brings the total iQPS mission count to 15, with seven already completed since 2023.
- This is iQPS’s second multi-launch order with Rocket Lab in just six months.
- Analysts hold a Moderate Buy consensus on RKLB, with an average price target of $86.77 — about 30% upside.
- The Neutron rocket, expected to launch in late 2026 or early 2027, is seen as a key growth catalyst.
Get live prices, charts, and KO Scores from KnockoutStocks.com, the data-driven platform ranking every stock by quality and breakout potential.
Rocket Lab has locked in another batch of launches with one of its most repeat customers, and Wall Street is watching closely to see if the company can turn momentum into margin.
Rocket Lab announced a new multi-launch agreement with the Institute for Q-shu Pioneers of Space (iQPS) for three additional Electron rocket missions. The launches are scheduled to begin no earlier than 2028 and will lift off from Launch Complex 1 in New Zealand.
The deal pushes the total mission count between the two companies to 15. Seven of those have already flown since 2023.
Notably, this is the second multi-launch order iQPS has placed with Rocket Lab in the past six months. That kind of repeat business is a sign of operational reliability.
The missions will deploy QPS-SAR satellites using Rocket Lab’s Motorized Lightband separation system. Each launch will be fully dedicated to iQPS payloads.
Brian Rogers, VP of Global Launch Services at Rocket Lab, pointed to consistent execution on past missions as the foundation of the partnership. The next iQPS launch is set for no earlier than May 2026.
Rocket Lab also recently closed its at-the-market equity offering, raising around $474 million in gross proceeds. The company has additional collared forward transactions in place with maximum expected proceeds of $642 million.
On the acquisition front, Rocket Lab received German regulatory approval for its planned purchase of Mynaric. That deal is expected to close in April for around $75 million.
Neutron in Focus
Revenue hit $601.8 million over the last twelve months, up 38% year-over-year. But analysts agree the bigger story is what comes next — Neutron.
The 43-meter partially reusable rocket is designed to compete with SpaceX’s Falcon 9 for satellite and cargo launches. Key components, including the “Hungry Hippo” fairing and thrust structure, are ready for final assembly.
Analyst Gregory Pendy at Clear Street said Neutron could tap a larger market and generate higher revenue per mission than Electron — making it a central growth driver if the timeline holds.
What Analysts Are Saying
Citizens’ Trevor J. Walsh upgraded RKLB from Hold to Buy this week, keeping his price target at $85. Walsh cited the current price as an attractive entry point and pointed to Rocket Lab’s push into defense and space services as a path to better margins.
Roth MKM’s Sujeeva De Silva maintained a Buy rating with a $90 target. De Silva highlighted Rocket Lab’s growing backlog and its expansion into satellite components as evidence the company is successfully moving beyond launch alone.
Across the board, RKLB holds a Moderate Buy consensus on TipRanks — 10 Buys and 5 Holds over the last three months. The average price target sits at $86.77, implying roughly 30% upside from current levels.
RKLB was down 3.39% on the day of the announcement.
🚨 Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!




